Tempest Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2026 | 269.77 K | $774.25 K | 0.00% | 6.50% |
| SABBY MANAGEMENT, LLC | 02/17/2026 | 178.59 K | $512.56 K | 100.00% | 4.30% |
| VANGUARD GROUP INC | 01/29/2026 | 162.56 K | $466.55 K | 0.00% | 3.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 44.11 K | $126.60 K | 7.53% | 1.06% |
| BLACKROCK, INC. | 02/12/2026 | 39.07 K | $112.13 K | 0.00% | 0.94% |
| FMR LLC | 02/17/2026 | 33.23 K | $95.36 K | 0.00% | 0.80% |
| UBS GROUP AG | 01/29/2026 | 17.54 K | $50.35 K | 54.03% | 0.42% |
| NORTHERN TRUST CORP | 02/17/2026 | 14.05 K | $40.33 K | 100.00% | 0.34% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 11.44 K | $32.84 K | 100.00% | 0.28% |
| DRW SECURITIES, LLC | 02/12/2026 | 10.45 K | $29.98 K | -44.51% | 0.25% |
| MORGAN STANLEY | 02/13/2026 | 2.06 K | $5.91 K | -2.37% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 1.61 K | $4.62 K | -2.54% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.33 K | $3.80 K | 100.00% | 0.03% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 1.08 K | $3.10 K | 134.78% | 0.03% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 292 | $838 | 0.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 239 | $686 | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 56 | $161 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 37 | $107 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 02/11/2026 | 18 | $52 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 3 | $9 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BELVEDERE TRADING LLC | 02/10/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tempest Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Tempest Therapeutics Inc. The most heavily invested institutionals were:
Versant Venture Management, LLC: 269,772
SABBY MANAGEMENT, LLC: 178,592
VANGUARD GROUP INC: 162,560
GEODE CAPITAL MANAGEMENT, LLC: 44,112
BlackRock, Inc.: 39,068
FMR LLC: 33,225
18.98% of Tempest Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.32 M shares in the last 24 months. This purchase volume represents approximately $3.16 M in transactions.